Skip to main content
Premium Trial:

Request an Annual Quote

Michael Stapleton, Joseph Mollica, Hanne Dannulat, David Muth


Michael Stapleton has resigned as COO of Accelrys, the software division of Pharmacopeia. He will stay with the company until December 31, 2002. Until a replacement is hired, Joseph Mollica, CEO of Pharmacopeia, will serve as acting COO of Accelrys. The company did not provide further details on Stapleton’s departure.

Hanne Dannulat has joined San Diego-based Structural Bioinformatics as European managing director. Dannulat most recently held positions in the areas of sales, sales management, marketing, new product launches, and strategic planning with Glaxo Wellcome and GlaxoSmith-Kline. She will be responsible for planning and management of SBI’s European commercial operation and will report directly to David Muth, president and COO.

Filed under

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.